CAS: 3590-05-4; Acetylazide

该化合物是一种化学化合物,其特点是用甲氧基化合物组和与硫化物组相连的乙酰胺酸性动物替代的丙酰胺环,具有一种被替换为甲状腺环状物环状物状物状物状的化合物,该化合物具有典型的硫化物状衍生物特征,由于其抑制细菌叶酸合成的能力,这些衍生物通常具有抗菌性.甲状腺素组的存在可能会加强其亲脂性,有可能影响其生物利用率和与生物目标的相互作用.该化合物在室温室温度下可能很固,并可能表现出极地溶剂中的中等溶性.其结构表明其在医药化学中的潜在用途,特别是在研制抗微生物剂方面.与许多氟化物状物状物衍生物衍生物的特性可能受到具体的监管因素的制约.还需要进一步研究,以充分阐明其生物活动,毒性和潜在治疗用途.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-8071132-B2
      优先权日:2004-06-01
      标 题:Unagglomerated core/shell nanocomposite particles
      发明人:ADAIR JAMES H; ROUSE SARAH M; WANG JUN; KESTER MARK; SIEDLECKI CHRISTOPHER; WHITE WILLIAM B; VOGLER ERWIN; SNYDER ALAN; PANTANO CARLO G; RUIZ-VELASCO VICTOR; SINOWAY LAWRENCE
      权利人:ADAIR JAMES H; ROUSE SARAH M; WANG JUN; KESTER MARK; SIEDLECKI CHRISTOPHER; WHITE WILLIAM B; VOGLER ERWIN; SNYDER ALAN; PANTANO CARLO G; RUIZ-VELASCO VICTOR; SINOWAY LAWRENCE; PENN STATE RES FOUND
      摘要:The present invention provides a method for the synthesis of unagglomerated, highly dispersed, stable core/shell nanocomposite particles comprised of preparing a reverse micelle microemulsion that contains nanocomposite particles, treating the microemulsion with a silane coupling agent, breaking the microemulsion to form a suspension of the nanocomposite particles by adding an acid/alcohol solution to the microemulsion that maintains the suspension of nanocomposite particles at a pH of between about 6 and 7, and simultaneously washing and dispersing the suspension of nanocomposite particles, preferably with a size exclusion HPLC system modified to ensure unagglomeration of the nanocomposite particles. The primary particle size of the nanocomposite particles can range in diameter from between about 1 to 100 nm, preferably from between about 10 to 50 nm, more preferably about 10 to 20 nm, and most preferably about 20 nm.

      专利号:US-7078406-B2
      优先权日:2001-10-09
      标 题 :Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
      发明人:CARVER JR THEODORE E; RINKER JAMES M
      权利人:JOHNSON & JOHNSON PHARM RES
      摘要:The present invention is directed to a compound of Formula I: n nwherein A, R 1 , and R 2 are defined herein. The present invention is also directed to compositions comprising compounds of Formula I, methods of using compounds of Formula I, and methods of making compounds of Formula I.

      专利号:US-9149445-B2
      优先权日:2009-07-27
      标 题:Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections
      发明人:LIU SEAN; RABINOWITZ JOSHUA D; SHENK THOMAS
      权利人:LIU SEAN; RABINOWITZ JOSHUA D; SHENK THOMAS; UNIV PRINCETON
      摘要:A method of treating or preventing a viral infection in a mammal by administering a compound or pharmaceutically acceptable derivative thereof that inhibits a phosphatidic acid synthesis enzyme.

      专利号:MX-PA04003451-A
      优先权日:2001-10-09
      标 题:SUBSTITUTED DIFENYLOXAZOLS, THE SYNTHESIS OF THE SAME AND THE USE OF THE SAME AS FLUORESCENCE DETECTORS.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:S6 | ITNANTIBIOTIC | Antibiotic List from the ITN MSCA ANSWER | DOI:10.5281/zenodo.2621956
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知